BioTheryX Announces $35 Million Series D Financing

2021-12-29T08:50:39-08:00July 28, 2020|

SAN DIEGO, CA, July 28, 2020 -- BioTheryX, Inc., a clinical stage biotechnology company harnessing the power of protein modulation [...]